[2] 邢豫宾,戴路明,赵芝焕,等. 血清降钙素原和常用炎症指标结合 SOFA 评分对脓毒症早期诊断和预后价值的评价[J]. 中国危重病急救医学,2008,20(1):23-28.
[2] Joo K,Park W,Lim MJ,et al. Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases[J]. J Korean Med Sci,2011,26(9):1147-1151.
[3] Theodorou VP,Papaioannou VE,Tripsianis GA,et al. Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheterrelated bloodstream infections in selected critically ill patients:a prospective observational study[J]. BMC Infect Dis,2012,12:247.
[4] Kasamatsu Y,Yamaguchi T,Kawaguchi T,et al. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia [J]. Respirology,2012,17(2):330-336.
[5] 戴佩佩,裘晓乐,徐克. 降钙素原与 C 反应蛋白联合检测在细菌感染中的应用[J]. 检验医学,2010,25(11):858-860.
[6] Bustos BR,Araneda CH. Procalcitonin for the diagnosis of late onset sepsis in newborns of very low birth weight[J]. Rev Chilena Infectol,2012,29(5):511-516.
[7] Khorvash F,Abdi F,Dialami K,et al. Can serum procalcitonin and C-reactive protein as nosocomial infection markers in hospitalized patients without localizing signs? [J]. J Res Med Sci,2011,16(10):1280-1285.
[8] Dusemund F,Bucher B,Meyer S,et al. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance[J]. Eur J Clin Microbiol Infect Dis,2013,32(1):51-60.
[9] Li H,Luo YF,Blackwell TS,et al. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections[J]. Antimicrob Agents Chemother,2011,55(12):5900-5906.